Desq Long
Sign in

Company

NEUROCRINE BIOSCIENCES INC

NBIX · CIK 0000914475

SEC FORM 4
$363,284.81

NEUROCRINE BIOSCIENCES INC (NBIX)

Sale of 2,311 shares at $157.1981 per share.

Reporting Person ABERNETHY MATT · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001724097-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$130,050.56

NEUROCRINE BIOSCIENCES INC (NBIX)

Sale of 826 shares at $157.4462 per share.

Reporting Person Boyer David W. · Officer Title Chief Corp. Affairs Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001909817-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 14,343 shares at $0 per share.

Reporting Person GORMAN KEVIN CHARLES · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001201096-26-000018 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,224,608.58

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 7,839 shares at $156.22 per share.

Reporting Person GORMAN KEVIN CHARLES · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001201096-26-000018 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 4,483 shares at $0 per share.

Reporting Person Lippoldt Darin · Officer Title Chief Legal Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001504783-26-000019 · filed 2026-09-15 · View filing →

SEC FORM 4
$377,896.18

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 2,419 shares at $156.22 per share.

Reporting Person Lippoldt Darin · Officer Title Chief Legal Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001504783-26-000019 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 6,275 shares at $0 per share.

Reporting Person Gano Kyle · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001567160-26-000009 · filed 2026-09-15 · View filing →

SEC FORM 4
$528,960.92

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 3,386 shares at $156.22 per share.

Reporting Person Gano Kyle · Officer Title Chief Executive Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001567160-26-000009 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 1,842 shares at $0 per share.

Reporting Person Gano Kyle · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001567160-26-000009 · filed 2026-09-15 · View filing →

SEC FORM 4
$155,282.68

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 994 shares at $156.22 per share.

Reporting Person Gano Kyle · Officer Title Chief Executive Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001567160-26-000009 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 6,275 shares at $0 per share.

Reporting Person BENEVICH ERIC · Officer Title Chief Commercial Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001643653-26-000018 · filed 2026-09-15 · View filing →

SEC FORM 4
$528,960.92

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 3,386 shares at $156.22 per share.

Reporting Person BENEVICH ERIC · Officer Title Chief Commercial Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001643653-26-000018 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 5,020 shares at $0 per share.

Reporting Person ABERNETHY MATT · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001724097-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$423,199.98

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 2,709 shares at $156.22 per share.

Reporting Person ABERNETHY MATT · Officer Title Chief Financial Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001724097-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 3,587 shares at $0 per share.

Reporting Person Cooke Julie · Officer Title Chief Human Resources Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001776977-26-000013 · filed 2026-09-15 · View filing →

SEC FORM 4
$302,441.92

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 1,936 shares at $156.22 per share.

Reporting Person Cooke Julie · Officer Title Chief Human Resources Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001776977-26-000013 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 3,914 shares at $0 per share.

Reporting Person Keswani Sanjay Chandru · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001818524-26-000006 · filed 2026-09-15 · View filing →

SEC FORM 4
$329,936.64

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 2,112 shares at $156.22 per share.

Reporting Person Keswani Sanjay Chandru · Officer Title Chief Medical Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001818524-26-000006 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 3,587 shares at $0 per share.

Reporting Person Onyia Jude · Officer Title Chief Scientific Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001894425-26-000020 · filed 2026-09-15 · View filing →

SEC FORM 4
$302,441.92

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 1,936 shares at $156.22 per share.

Reporting Person Onyia Jude · Officer Title Chief Scientific Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001894425-26-000020 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 3,587 shares at $0 per share.

Reporting Person Boyer David W. · Officer Title Chief Corp. Affairs Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001909817-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$302,441.92

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 1,936 shares at $156.22 per share.

Reporting Person Boyer David W. · Officer Title Chief Corp. Affairs Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001909817-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code A) of 4,483 shares at $0 per share.

Reporting Person Delaet Ingrid · Officer Title Chief Regulatory Officer · Transaction Code A

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001965808-26-000015 · filed 2026-09-15 · View filing →

SEC FORM 4
$377,896.18

NEUROCRINE BIOSCIENCES INC (NBIX)

Disposition (code F) of 2,419 shares at $156.22 per share.

Reporting Person Delaet Ingrid · Officer Title Chief Regulatory Officer · Transaction Code F

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001965808-26-000015 · filed 2026-09-15 · View filing →

SEC FORM 4
$138,108.56

NEUROCRINE BIOSCIENCES INC (NBIX)

Acquisition (code M) of 3,194 shares at $43.24 per share.

Reporting Person BENEVICH ERIC · Officer Title Chief Commercial Officer · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001643653-26-000016 · filed 2026-09-10 · View filing →

SEC FORM 4
$333,029.94

NEUROCRINE BIOSCIENCES INC (NBIX)

Sale of 2,154 shares at $154.61 per share.

Reporting Person BENEVICH ERIC · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001643653-26-000016 · filed 2026-09-10 · View filing →